Kolexia
Schwiertz-Jurus Verane
Pharmacien
Hôpital Lyon Sud
Pierre-Bénite, France
134 Activités
625 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Tumeurs du sein Lymphome B Tumeurs hématologiques Lymphome B diffus à grandes cellules Épistaxis Maladies rares Myélome multiple Télangiectasie hémorragique héréditaire

Industries

Pfizer
7 collaboration(s)
Dernière en 2023
Gilead
6 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2023
BMS
3 collaboration(s)
Dernière en 2023

Dernières activités

Cancer du sein et recherche clinique - HCL
Youtube @ HCL - Hospices Civils de Lyon   28 avril 2023
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood advances   06 mars 2023
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review.
Journal of cancer research and clinical oncology   28 février 2023
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.
Cancer chemotherapy and pharmacology   25 février 2023
Comparing different robots available in the European market for the preparation of injectable chemotherapy and recommendations to users.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   14 décembre 2022
QOLD CAR-T: Pilot Study for Quality Of Life and Drug Use Assessment in Patients With CAR-T Cells
Essai Clinique (Hospices Civils de Lyon)   01 février 2022
ELLIPSE: The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia.
Essai Clinique (Hospices Civils de Lyon)   14 octobre 2021
Preparations of exploration of immediate hypersensitivity to antineoplastic agents: An oncology pharmacy perspective.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   21 septembre 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Clinical nuclear medicine   08 juillet 2021
Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Journal of cancer research and clinical oncology   29 avril 2021